Table 2.
Comparison among the main characteristics of the three populations
| LVAD vs. HT | HT vs. HF | HF vs. LVAD | ||||
|---|---|---|---|---|---|---|
| Age | z: −0.8 | P: 0.38 | z: −1.7 | P: 0.09 | z: −0.7 | P: 0.47 |
| Male gender | 0.06 | P: 0.9 | z: −1.09, | P: 0.27 | : −1.07 | P: 0.3 |
| Smoke | z: −0.9 | P:0.3 | z: −1.14 | P:0.25 | z: −0.04 | P:0.9 |
| BMI | t: 3.1 | P: 0.003 | t: −1.6 | P: 0.12 | t: 1.6 | P: 0.12 |
| Heart rate | t: −3.1 | P: 0.003 | t: 7.9 | P: 0.0001 | t: 3.2 | P: 0.02 |
| NT‐pro BNP | z: −1.3 | P: 0.2 | z: −4.7 | P: 0.000 | z: −2.8 | P: 0.005 |
| CRP | z: −0.1 | P: 0.9 | z: −0.5 | P: 0.6 | z: −0.8 | P: 0.4 |
| Baseline diameter a | z: −0.3 | P:0.7 | z: −0.6 | P: 0.5 | z: −0.8 | P: 0.4 |
| Peak diameter a | z: −0.4 | P:0.7 | z: −0.5 | P:0.6 | z: −0.9 | P: 0.4 |
| Absolute FMD change | z: −0.3 | P: 0.8 | z: −0.09 | P: 0.9 | z: −0.2 | P:0.8 |
| Percentage FMD change | z: −0.05 | P: 0.9 | z: −0.2 | P: 0.8 | z: −0.04 | P: 0.9 |
| LVEF (%) | z: −7.1 | P: 0.000 | z: −8.4 | P: 0.0001 | z: −1.2 | P:0.2 |
| Ischaemic aetiology | z: −1.6 | P: 0.1 | z: −1.8 | P: 0.1 | z: −2.8 | P: 0.005 |
Abbreviations: BMI, body mass index; CRP, C‐reactive protein; FMD, flow‐mediated dilation; HF, heart failure; HT, heart transplantation; LVAD, left ventricular assist device; LVEF, left ventricle ejection fraction.
Statistical significance was considered for P < 0.05.
a
Of brachial artery.